Tolerogenic Iron Oxide Nanoparticles in Type 1 Diabetes: Biodistribution and Pharmacokinetics Studies in Nonobese Diabetic Mice.

MLA

Dubreil, Chloe, et al. “Tolerogenic Iron Oxide Nanoparticles in Type 1 Diabetes: Biodistribution and Pharmacokinetics Studies in Nonobese Diabetic Mice.” Small (Weinheim an Der Bergstrasse, Germany), vol. 14, no. 40, Oct. 2018, p. e1802053. EBSCOhost, https://doi.org/10.1002/smll.201802053.

APA

Dubreil, C., Sainte Catherine, O., Lalatonne, Y., Journé, C., Ou, P., van Endert, P., & Motte, L. (2018). Tolerogenic Iron Oxide Nanoparticles in Type 1 Diabetes: Biodistribution and Pharmacokinetics Studies in Nonobese Diabetic Mice. Small (Weinheim an Der Bergstrasse, Germany), 14(40), e1802053. https://doi.org/10.1002/smll.201802053

Chicago

Dubreil, Chloe, Odile Sainte Catherine, Yoann Lalatonne, Clément Journé, Phalla Ou, Peter van Endert, and Laurence Motte. 2018. “Tolerogenic Iron Oxide Nanoparticles in Type 1 Diabetes: Biodistribution and Pharmacokinetics Studies in Nonobese Diabetic Mice.” Small (Weinheim an Der Bergstrasse, Germany) 14 (40): e1802053. doi:10.1002/smll.201802053.